Investment Thesis
V-Bio Ventures co-creates startups and invests in early- to mid-stage companies with high growth potential, transforming scientific innovation into products that positively impact people’s lives by leveraging great science and empowering talented entrepreneurs.
Stage Focus
Early/mid
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Early- to mid-stage companies with differentiated technology addressing unmet medical needs, focusing on drug discovery and development
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€77,700,000 - €77,850,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (12)
A
Aurelie Nowack
Principal
C
Christina Takke
Managing Partner
D
Dennis Pedri
Analyst
D
Dennis Pedri 2959Ab78
Team Member
K
Katja Rosenkranz
Partner
M
Marti Nsolleveld
Team Member
M
Mathias Falcenberg
Venture Partner
S
Shelley Margetson
Managing Partner
T
Tom Schwarz
Strategic Advisory Board Member
T
Tom Schwarz 283A57111
Team Member
W
Ward Capoen
Partner
W
Willem Broekaert
Managing Partner
